Abstract Assessment of smokers' responses to individualized feedback of genetic susceptibility has shown little or no influence on smoking cessation outcomes. One explanation is that smokers may be having unintended responses that undermine the feedback's motivational impact (e.g., fatalism or downplaying risk). In preparation for a large randomized trial with college smokers, we conducted a qualitative pilot study to explore smokers' motives for genetic testing and how these motives might influence interpretation of genetic risk feedback. Prior to reviewing informational materials describing a test for the glutathione S-transferase M1 gene, 33 college smokers (18 to 21 years) participated in a 30-min, semistructured, openended interview regarding their attitudes on health risks, genetic testing in general, genetic testing for lung cancer risk, and informational needs regarding genetics and genetic testing for lung cancer risk. Two central themes emerged from an analysis of the interviews: general impressions of genetic testing and perceived value of genetic testing. Prominent in the second theme was the finding that genetic risk feedback may be unsuccessful in motivating quitting (a) due to skepticism about genetic tests, (b) participants dismissing genetic feedback as personally irrelevant, and (c) participants receiving lowrisk results justifying continued smoking in light of public health messages that "it's never too late to quit." These findings require careful consideration among health professionals looking to genetic risk feedback as a vehicle to motivate disease prevention or behavior change.
Introduction
New genetic tests that provide individualized susceptibility feedback on common health conditions are increasingly available in the marketplace (Bloss et al. 2010; Heshka et al. 2008; Koury 2003; Pollack 2010) . Although the clinical usefulness of these tests remains unknown and it is unclear whether these tests will be widely translated into clinical care, several commercial companies are selling them online and direct to the public (e.g., www.23andme.com, www. navigenics.com, www.decodeme.com). Indeed, scientific and medical leaders forecast that genetic tests will become more comprehensive in scope (e.g., capable of testing for multiple health conditions simultaneously) and cheaper in price in the coming decade (Hock et al. 2011; Hunter et al. 2008) .
One suggested benefit of genetic susceptibility testing is that risk feedback may motivate preventive behaviors among at-risk populations (Carpenter et al. 2007; McBride et al. 2010; O'Neill et al. 2009 ). In the case of smoking, several models of health behavior change (e.g., Health Belief Model, Precaution Adoption Process Model) lend support to this supposition by suggesting that personalized genetic risk feedback could increase the relevance of risk information and, in turn, smokers' perceptions of vulnerability to the harms of smoking and motivation to quit (Janz and Becker 1984; Lerman and Munafò 2007; Sanderson et al. 2008; Sanderson et al. 2010) . However, assessment of smokers' responses to individualized feedback of genetic susceptibility has shown little or no influence on smoking cessation outcomes (Marteau et al. 2010 ) and has tempered optimism about the motivational potential of such feedback.
Although some researchers have suggested that smokers' unintended reactions to genetic risk information (Henrikson et al. 2009 ) may partially explain poor cessation outcomes, it is as yet unclear how smokers will react to genetic information. Some researchers have voiced concerns that smokers may respond to high-risk feedback with increased fatalism and to low-risk feedback by downplaying their vulnerability. Consistent with these concerns is evidence that smokers are optimistic about their personal risk for avoiding health harms from smoking (Arnett 2000; McCoy et al. 1992) .
Research findings regarding how susceptibility testing and related risk communications might be interpreted are mixed (e.g., Marteau et al. 2010; Carlsten and Burke 2006; Ito et al. 2006; Lerman et al. 1997; McBride et al. 2002 McBride et al. , 2000 Sanderson et al. 2010 Sanderson et al. , 2009 . Studies with adult populations reported modest improvements in cessation outcomes Carpenter et al. 2007; Ito et al. 2006; Lerman et al. 1997; McBride et al. 2002; Sanderson et al. 2008 Sanderson et al. , 2009 . However, these studies have not fully explored why susceptibility feedback interventions fail to perform consistent with theory-based cessation hypotheses. Qualitative studies can provide useful insights by enabling exploration of smokers' motives for genetic susceptibility testing and how these motives might influence interpretation of genetic risk feedback. These insights can be used to generate hypotheses for future research (Weiner et al. 2011) .
College smokers are an important target audience for exploring concerns about susceptibility testing and related risk communications because they (1) are likely to have adequate literacy levels to understand basic genetic concepts so that misunderstanding, should it occur, can more readily be attributed to motivated reasoning (Kunda 1987) , (2) have the most to gain from effective cessation strategies because they have yet to experience the negative health effects of smoking, and (3) may be especially drawn to new biotechnologies (Amos et al. 2006; Cohn et al. 1995; Westmaas and Woicik 2005) .
In preparation for a large randomized trial evaluating the influence of offering college students feedback of genetic susceptibility to lung cancer, we explored college student smokers' interest in and motivations for genetic testing. The larger study seeks to evaluate whether genetic risk testing information previously evaluated in trials with older smokers (McBride et al. 2002; Sanderson et al. 2008 Sanderson et al. , 2009 ) is appropriate for younger smokers and to develop and refine information materials designed to motivate college smokers to take steps to quit. Before testing whether genetic risk feedback could motivate smoking cessation among young smokers and to anticipate possible reactions in the larger trial, we conducted a qualitative pilot study to explore the motives that young smokers bring to genetic testing decisions to gain insight into how these motives might influence their interpretation of test results.
Methods

Genetic susceptibility marker
Test materials were based on GSTM1, a gene in the glutathione S-transferase family of genes involved in the detoxification of carcinogens associated with increased risk for lung cancer (Sobti et al. 2008; Vineis et al. 2007 ). Both copies of the GSTM1 gene are missing in approximately 50% of the population. Meta-analytic research demonstrates an association between this common gene variant (called GSTM1-null or GSTM1-missing) and increased lung cancer risk (odds ratio=1.17, 95% CI, 1.07-1.27) (Benhamou et al. 2002) .
Sampling and recruitment
College smokers, age 18 to 21, were recruited between January 2008 and July 2008 from four postsecondary institutions in the southeastern United States (Duke University, North Carolina State University, North Carolina Central University, University of North Carolina at Chapel Hill) through posted flyers in student lounges, advertisements in the student newspapers, and electronic messages on internet sites (Facebook, My Space, Craig's List). We used a purposive sampling technique (Patton 2002 ) to recruit a sample that met the following inclusion criteria: (a) enrolled as a student in one of the four selected postsecondary institutions, (b) smoked at least one cigarette per week and at least 50 cigarettes in his/her lifetime, and (c) could speak and read English. Of the 82 students who called to inquire about the study, 17 were ineligible and 19 declined to participate. Of the 46 students who completed the telephone consent and baseline survey, two more were withdrawn because they were ineligible, one withdrew voluntarily prior to completion of the study, and ten were lost to follow-up prior to completion of the study, leading to a final sample size of 33 students.
Data collection and procedures
The study procedures were approved by the Duke University Medical Center's institutional review board for human subject research. Eligible participants gave verbal consent over the telephone and then completed a telephone survey that included demographic questions, assessment of smoking behavior, and beliefs about lung cancer risk. Participants were then scheduled to meet in a private room on campus with a nurse clinician/investigator (SD) experienced in the collection and analysis of qualitative data. During the scheduled meeting, participants signed a written consent and then completed a semistructured, open-ended interview that assessed attitudes related to health risks, genetic testing in general, genetic testing for lung cancer risk, and informational needs regarding genetics and genetic testing for lung cancer risk (Appendix). Participants received no information on the potential value or risk of genetic testing prior to the interview. Interviews lasted approximately 30 min and were audio-recorded then transcribed into text for analysis. Participants received US $40 for completing an interview.
Coding and analysis of data
Because the primary aim of this study was to describe college smokers' views about genetic testing for lung cancer risk, we used a descriptive analysis method that isolated common and idiosyncratic themes in the interview data with minimal interpretive opinions by the investigators (Sandelowski 2000) . Two analysts examined the transcripts (SD and a psychology graduate student trained in qualitative analysis) using a content analysis technique, which entails inductively interpreting information in text data through a systematic process of reading and re-reading each transcript, identifying categories and applying codes to patterns of data within categories (Hsieh and Shannon 2005) . The first ten transcripts were read, re-read, and coded independently by both analysts. Codes were compared, and a consensus process was used to determine the initial coding schema. Each analyst then coded 50% of the remaining 23 transcripts, and the coding schema was adapted as new codes were developed. A text-based software analysis program (ATLAS.ti v.5.0 2005) was used to assist with organizing the data and applying codes. We conducted data analysis concurrently with data collection so that analytic categories emerging from the interviews with the first few participants could be further explicated in interviews with subsequent participants. This procedure also allowed us to appreciate when categories became "saturated," defined as the point at which new information produces little change to the codebook (Guest et al. 2006) . Our categories became saturated and the codebook complete following 22 (67%) of the interviews. The remaining 11 interviews served to confirm the information in the categories. The categories were then grouped into two central themes.
Results
Demographic and smoking-related characteristics of participants As Table 1 shows, participants ranged in age from 18 to 21 years (mean, 20 years), 58% were male and 30% were African American (55% Caucasian, 9% Hispanic). Although the majority (75%) had made more than one serious quit attempt (i.e., longer than 24 h) in the past year, these smokers expressed a relatively modest desire to quit smoking (M=4.0 on a 7-point scale). Additionally, young smokers tended to view the likelihood of getting lung cancer if they continued smoking to be about average (M=4.2 on a 7-point scale) and that quitting smoking would lower this likelihood considerably (M=1.9 on a 7-point scale).
Content analyses of structured interviews
Two central themes emerged from the analysis of the transcribed interviews. We labeled these themes "general impressions of genetic testing" and "perceived value of genetic testing."
General impressions of genetic testing
About 62% of the participants reported some familiarity with genetic testing, e.g., "I don't know a whole lot about it … I haven't read a whole lot on it but it makes me think about getting your embryo genetically tested to see if the baby would have mental retardation or something, I don't really agree with the prenatal testing as much." However, when asked specifically about genetic testing for diseases, many participants talked confidently about DNA, proteins, prenatal testing, and other important concepts such as the search for heritable disorders. Some participants talked about personal risks for diseases, e.g., "To me, it means take a sample of my DNA or something and correlate it with my risk factors for different types of cancer," and "it's like trends or tendencies towards specific genetic diseases." These comments suggest awareness that genetic information can be probabilistic rather than deterministic. Although participants demonstrated awareness of basic concepts, they appeared to have limited personal experience with genetic testing related to cancer risk.
Participants inquired about the accuracy, validity, cost, and reliability of genetic tests and expressed concerns about insurance as well as fear of receiving deterministic information. For example, one participant's comment illustrates concerns about the validity of the tests, "It is not always easy to trust whether the test is fully backed-up and researched." Another expressed distrust in the ways that these tests might be used and concerns about what the information might convey, "I mean, if you want to get it, you can, but insurance companies will charge you more. But I don't think I'd want to get it. No, I mean what's the difference …the knowledge of when I'm gonna die…. I mean I'm gonna die regardless."
Perceived value of genetic testing
Participants generally downplayed the value of genetic susceptibility testing. Several justified these views by referring to public health messages that tell young smokers that lungs repair quickly after individuals quit smoking. A common theme was that these young smokers perceived their exposure levels to be too low to induce risk, making genetic risk assessment irrelevant. One student expanded further on this point by conveying optimism that she would eventually quit as a reason for not getting tested, "Possibly lung cancer, but I'm not too worried about that. On a scale of 1 to 10, I'm a 2 on that worry. It (smoking) helps with school stress and they say that once you quit your lungs will repair within 2 years, or something. So I figure I can quit after graduate school and my lungs will be great by the time I'm 25." Another student responded similarly, in response to the question, "Would you want to be tested?," "I wouldn't want to know because I am going to quit in a few years anyway … and they say your lungs regenerate or something, so they are normal again… so why worry?" Others felt that they had insufficient exposure to even be curious about susceptibility, e.g., "Maybe I would be interested if I had been smoking for, you know, a really long time…like more than 4 years." Also indicative of perceived value of genetic testing was that only one third of the participants expressed interest in taking "a genetic test for lung cancer risk." Participants who were interested indicated that they believed the test result might motivate them to quit smoking. For example, one student stated, "..cause I've been smoking for a while so this might be the final break that'll make me quit"; or another student reported, "It might open my eyes cause I know that I risk something that I'm doing and I think it might be like the breaking point." However, others acknowledged that it also might provide justification for continued smoking. For example, one participant expressed that low-risk genetic test results could give false reassurance and possibly delay quitting stating, "Now that I think about it, if I found out that I were more prone to getting lung cancer, I would probably be a lot more ready to quit. But if I got the test that said, 'um, you don't really have that gene', then I would probably not be as willing to quit. It would probably be like, 'I can probably get away with it for a little bit longer' when I should quit regardless. It might make me feel safer than I am."
Smokers that expressed least favorable opinions towards genetic testing for lung cancer often questioned the validity of the test or its true association with cancer. For example, one participant questioned the link between genes, heredity, and lung cancer by describing his family's extensive history of smoking, "I'm still impressed that my grandpa could smoke two packs of cigarettes and not develop any form of cancer at all. My dad has smoked, my other grandpa has smoked, too and they didn't present any symptoms of cancer; neither tongue or lung or just any form, so I would like to know if there's actually like a real correlation." Several expressed concerns about their need to understand the privacy and confidentiality of the test result and whether the test would allow for other information to be discovered and shared without their knowledge. For example, one participant described her fears as, "I heard that, in the future, when you apply for a job they could find out stuff about your information, and then maybe they discriminate and not give you the job if they thought you might get sick one day. So I think we need to protect our information."
Discussion
Emerging genetic susceptibility tests are forecast to have promise for motivating individuals to adopt risk reducing behaviors, although critical evidence is yet to support this expectation. These genetic tests may hold particular advantage for young healthy adults for whom adoption of healthy lifestyles could have the greatest benefit for disease prevention. However, results from this qualitative study indicate that young smokers may not respond to offers of genetic testing for susceptibility to smoking-related diseases as expected at this present time. Participants expressed general awareness of concepts and a sound scientific foundation for understanding test results. However, they had limited specific knowledge or personal experience with cancer. This finding contrasts with findings from other areas of genetic testing, such as testing for hereditary cancers. Individuals who seek this more predictive type of genetic testing have personal and/or familial contact with the disease. This experience can shape their general awareness, attitudes, and responses to testing (Mogilner et al. 1998; Perez et al. 2011; Sussner et al. 2010) . Although our college smokers demonstrated general awareness of genetic susceptibility testing and specific knowledge of genetic concepts, several themes emerged that require careful consideration among health professionals looking to use genetic testing as a vehicle to motivate disease prevention or behavior change.
Participants acknowledged two alternative potential reactions to the information, both of which would be counterproductive to smoking cessation. They noted that high-risk feedback might foster fatalism about lung cancer and that low-risk results might justify continued smoking. They reported that both outcomes would undermine their motivation to quit smoking. Indeed, this potential led them to be cautious about considering genetic testing themselves despite the fact that a recent review shows that fatalism does not routinely occur after receipt of genetic test results (Collins et al. 2011) . Additionally, while our participants were somewhat curious about genetic testing for lung cancer risk, they were cautious about placing too much trust in the validity of the test results and were rightly skeptical of the magnitude of the risk conferred by being at high risk in this context. Several participants made comments that suggested genetic testing for lung cancer risk would be irrelevant to them because their smoking behavior was not particularly harmful. Specifically, participants reported that their lifetime experience with smoking was insufficient to prompt concerns with lung cancer and to necessitate genetic screening at this time. In addition, they reported that public health messages suggesting that smokers' lungs recover from the damage of smoking once they quit smoking reduced the urgency of quitting. This latter message was originally designed to underscore the benefits of quitting, even for long-term smokers. However, our college smokers recast the message for their own benefit, concluding that they can eliminate harms of smoking by eventually quitting. Importantly, results from addiction studies reveal the danger of this belief by showing that nicotine addiction becomes entrenched over time, making quitting more difficult the longer one smokes (Amos et al. 2006; Tucker et al. 2002; Wiltshire et al. 2005) . Research is needed exploring smokers' reactions to genetic testing for SNPs and other genetic variants associated with nicotine addiction (Wright et al. 2003 ). Although our sample was not selected to allow for testing of subgroup differences, we found no overt variations in reactions based on sex, race, or smoking experience.
Collectively, these findings lead us to speculate that the selfserving perceptions held by smokers in general may be held even more firmly by young smokers, and that these perceptions may have implications for how young smokers respond to the potential availability of genetic testing. Moreover, the education and numeracy that make college students better able to understand genetic risk communication may also aid them in reinterpreting risk information in ways that allow them to sustain their biases so that they can continue smoking.
The purpose of our study was to explore how college smokers' react to information about their personal risk for lung cancer and to obtain data that we and other researchers might use to generate hypotheses. Importantly, our data are preliminary and based on interviews conducted at one point in time with a small sample of college smokers. The findings may not generalize to non-college samples. Nevertheless, our findings lead us to predict that interventions designed to increase quitting by providing genetic risk feedback may be unsuccessful if they do not address (a) skepticism about genetic tests, (b) reactions to feedback that undermine the motivation to quit, and (c) the self-serving ways smokers can dismiss genetic feedback as personally irrelevant. More to the point, our findings suggest that genetic risk feedback by itself may be insufficient to induce behavioral change among young smokers.
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